News
ELAT
21.32
0.00%
0.00
BUZZ-Animal health companies rise after screwworm case in Texas
Reuters · 06/04 14:07
ELANCO ANIMAL HEALTH - OFFERS TREATMENT OPTIONS FOR LIVESTOCK AND PETS AGAINST NEW WORLD SCREWWORM
Reuters · 06/04 10:26
Elanco survey shows US pet owners keep pet health spending steady despite rising costs
PUBT · 06/03 11:26
Elanco Animal Health shareholders elect directors at annual meeting
PUBT · 05/27 21:01
Elanco EVP Rajeev Modi acquires 4,911 common shares worth $99,923.85
PUBT · 05/19 20:40
Elanco CEO Jeffrey Simmons acquires 4,971 shares for $99,874.54
PUBT · 05/19 20:39
ELANCO LAUNCHES BEFRENA™ (TIRNOVETMAB), NEW ANTI-IL-31 MONOCLONAL ANTIBODY, A BREAKTHROUGH ADDITION TO THE $1.3 BILLION U.S. CANINE DERMATOLOGY MARKET
Reuters · 05/18 11:27
BUZZ-U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
Reuters · 05/06 17:51
BUZZ-U.S. STOCKS ON THE MOVE-DaVita, Knight-Swift, Madrigal Pharma
Reuters · 05/06 15:50
BUZZ-U.S. STOCKS ON THE MOVE-Walt Disney, CVS, Uber
Reuters · 05/06 13:24
BUZZ-U.S. STOCKS ON THE MOVE-AMD, Apollo, Deckers Outdoor
Reuters · 05/06 11:39
BUZZ-Elanco jumps on annual forecast raise
Reuters · 05/06 11:22
Elanco Animal Health Q1 revenue and adjusted profit beats, lifts outlook
Reuters · 05/06 10:35
BRIEF-Elanco Animal Health Q1 Revenue USD 1,371 Million Vs. IBES Estimate USD 1,288 Million
Reuters · 05/06 10:27
Elanco Q1 FY26 adjusted EPS rises 8% to $0.40; revenue climbs 15% to $1.37 billion
PUBT · 05/06 10:27
ELANCO ANIMAL HEALTH REPORTS FIRST QUARTER 2026 RESULTS
Reuters · 05/06 10:27
Elanco Animal Health publishes 2025 annual report
PUBT · 05/06 09:09
Elanco Animal Health announces annual shareholder meeting via virtual webcast
PUBT · 05/04 15:58
Elanco wins FDA emergency authorization for Negasunt against New World screwworm in livestock
PUBT · 04/27 22:24
US FDA: ISSUED EMERGENCY USE AUTHORIZATION FOR NEGASUNT POWDER TO PREVENT & TREAT NEW WORLD SCREWWORM IN MULTIPLE SPECIES
Reuters · 04/27 20:12
More
Webull provides a variety of real-time ELAT stock news. You can receive the latest news about Elanco Animal Health Inc through multiple platforms. This information may help you make smarter investment decisions.
About ELAT
Elanco Animal Health Incorporated is an animal health company. The Company is focused in delivering products and services to prevent and treat disease in farm animals and pets. Its portfolio serves animals across its core species consisting of dogs, cats and cattle, poultry, swine, sheep and aqua. It offers products in two primary categories: Pet Health and Farm Animal. Its Pet Health portfolio is focused on parasiticides, vaccines and therapeutics. Its parasiticide portfolios in the pet health sector include species and formulations, with products that protect pets from worms, fleas and ticks. Its over-the-counter treatments include Seresto, Advantage, Advantix, Advocate, Credelio, Interceptor Plus and Trifexis. Its farm animal portfolio consists of products designed to prevent, control and treat health challenges primarily focused on cattle. Its products include medicated feed additives, antibiotics, vaccines, such as Rumensin and Baytril. Its poultry products are Maxiban and others